The weighting could be adjusted by the required ancillary testing (e.g., MSI testing in endometrial cancer)/ancillary testing recommended by consensus statements (elastin staining to assess for lymphatic invasion/vascular invasion in colorectal cancer resections). This evidence concerns the gene ELN and colorectal cancer.